Literature DB >> 11390616

ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells.

W P Halford1, C D Kemp, J A Isler, D J Davido, P A Schaffer.   

Abstract

In a previous study, we demonstrated that infected-cell polypeptide 0 (ICP0) is necessary for the efficient reactivation of herpes simplex virus type 1 (HSV-1) in primary cultures of latently infected trigeminal ganglion (TG) cells (W. P. Halford and P. A. Schaffer, J. Virol. 75:3240-3249, 2001). The present study was undertaken to determine whether ICP0 is sufficient to trigger HSV-1 reactivation in latently infected TG cells. To test this hypothesis, replication-defective adenovirus vectors that express wild-type and mutant forms of ICP0 under the control of a tetracycline response element (TRE) promoter were constructed. Similar adenovirus vectors encoding wild-type ICP4, wild-type and mutant forms of the HSV-1 origin-binding protein (OBP), and wild-type and mutant forms of VP16 were also constructed. The TRE promoter was induced by coinfection of Vero cells with the test vector and an adenovirus vector that expresses the reverse tetracycline-regulated transactivator in the presence of doxycycline. Northern blot analysis demonstrated that transcription of the OBP gene in the adenovirus expression vector increased as a function of doxycycline concentration over a range of 0.1 to 10 microM. Likewise, Western blot analysis demonstrated that addition of 3 microM doxycycline to adenovirus vector-infected Vero cells resulted in a 100-fold increase in OBP expression. Wild-type forms of ICP0, ICP4, OBP, and VP16 expressed from adenovirus vectors were functional based on their ability to complement plaque formation in Vero cells by replication-defective HSV-1 strains with mutations in these genes. Adenovirus vectors that express wild-type forms of ICP0, ICP4, or VP16 induced reactivation of HSV-1 in 86% +/- 5%, 86% +/- 5%, and 97% +/- 5% of TG cell cultures, respectively (means +/- standard deviations). In contrast, vectors that express wild-type OBP or mutant forms of ICP0, OBP, or VP16 induced reactivation in 5% +/- 5%, 8% +/- 0%, 0% +/- 0%, and 13% +/- 6% of TG cell cultures, respectively. In control infections, an adenovirus vector expressed green fluorescent protein efficiently in TG neurons but did not induce HSV-1 reactivation. Therefore, expression of ICP0, ICP4, or VP16 is sufficient to induce HSV-1 reactivation in latently infected TG cell cultures. We conclude that this system provides a powerful tool for determining which cellular and viral proteins are sufficient to induce HSV-1 reactivation from neuronal latency.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390616      PMCID: PMC114330          DOI: 10.1128/JVI.75.13.6143-6153.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency.

Authors:  W Cai; T L Astor; L M Liptak; C Cho; D M Coen; P A Schaffer
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

3.  Construction and characterization of herpes simplex virus type 1 mutants with conditional defects in immediate early gene expression.

Authors:  C M Preston; R Mabbs; M J Nicholl
Journal:  Virology       Date:  1997-03-03       Impact factor: 3.616

4.  Analysis of the promoter sequences of the UL9 gene of herpes simplex virus type 1.

Authors:  S P Deb; S Deb; D R Brown
Journal:  Biochem Biophys Res Commun       Date:  1993-06-15       Impact factor: 3.575

5.  Effect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo.

Authors:  M J Farrell; T P Margolis; W A Gomes; L T Feldman
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

6.  Genetic analysis of the herpes simplex virus type 1 UL9 gene: isolation of a LacZ insertion mutant and expression in eukaryotic cells.

Authors:  A K Malik; R Martinez; L Muncy; E P Carmichael; S K Weller
Journal:  Virology       Date:  1992-10       Impact factor: 3.616

7.  Characterization of dexamethasone-induced reactivation of latent bovine herpesvirus 1.

Authors:  D Rock; J Lokensgard; T Lewis; G Kutish
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells.

Authors:  W Cai; P A Schaffer
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

9.  Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency.

Authors:  N M Sawtell; R L Thompson
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia.

Authors:  N M Sawtell; R L Thompson
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more
  78 in total

1.  Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters.

Authors:  Bretton C Summers; David A Leib
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

2.  Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4.

Authors:  Luis M Schang; Andrew Bantly; Priscilla A Schaffer
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo.

Authors:  R L Thompson; May T Shieh; N M Sawtell
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 4.  Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.

Authors:  Ryan Hagglund; Bernard Roizman
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

5.  Experimental human cytomegalovirus latency in CD14+ monocytes.

Authors:  Danna Hargett; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

6.  Reversal of heterochromatic silencing of quiescent herpes simplex virus type 1 by ICP0.

Authors:  Michael W Ferenczy; Neal A DeLuca
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

7.  Herpes simplex virus-1 disarms the unfolded protein response in the early stages of infection.

Authors:  Heather F Burnett; Timothy E Audas; Genqing Liang; Rui Ray Lu
Journal:  Cell Stress Chaperones       Date:  2012-01-20       Impact factor: 3.667

8.  Stress-induced cellular transcription factors expressed in trigeminal ganglionic neurons stimulate the herpes simplex virus 1 ICP0 promoter.

Authors:  Devis Sinani; Ethan Cordes; Aspen Workman; Prasanth Thunuguntia; Clinton Jones
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

9.  Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

10.  Attenuation of the adaptive immune response in rhesus macaques infected with simian varicella virus lacking open reading frame 61.

Authors:  Christine Meyer; Amelia Kerns; Kristen Haberthur; Jesse Dewane; Joshua Walker; Wayne Gray; Ilhem Messaoudi
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.